Cipher Pharmaceuticals
is a Canada-based pharmaceutical company that operates brands developing novel therapies to treat conditions such as acute care and dermatology... Read moreCipher Pharmaceuticals
is a Canada-based pharmaceutical company that operates brands developing novel therapies to treat conditions such as acute care and dermatology... Read more
News
Sep 02, 2026
Nasdaq
Cipher Pharmaceuticals: Cipher Pharmaceuticals Secures Court Confirmation Of Arbitration Award
Sep 01, 2026
Marketscreener
Cipher Pharmaceuticals: Cipher Pharmaceuticals' Ownership Of Certain Abscoria-Related Clinical Data Affirmed by US Court
Aug 12, 2026
Nasdaq
Cipher Pharmaceuticals: CIPHER PHARMACEUTICALS INC Profit Retreats In Q2
Aug 11, 2026
Cision Canada
Press Release: Cipher Pharmaceuticals : Cipher Pharmaceuticals Reports Second Quarter 2026 Results
Aug 11, 2026
Seeking Alpha
Cipher Pharmaceuticals: Cipher Pharmaceuticals GAAP EPS of $0.16 misses by $0.03, revenue of $12.1M misses by $1.48M
Jul 08, 2026
Pharmabiz
Cipher Pharmaceuticals: Cipher Pharma and the panCanadian Pharmaceutical Alliance sign LOI for public drug plan coverage of Epuris
Jun 18, 2026
Cision Canada
Press Release: Cipher Pharmaceuticals : Cipher Pharmaceuticals Announces Results of Annual General Meeting of Shareholders
May 23, 2026
Yahoo
Cipher Pharmaceuticals: Why The Cipher Pharmaceuticals (TSX:CPH) Story Is Shifting As Analysts Lift Valuation Targets
May 11, 2026
Yahoo
Cipher Pharmaceuticals: Results: Cipher Pharmaceuticals Inc. Beat Earnings Expectations And Analysts Now Have New Forecasts
May 08, 2026
Seeking Alpha
Cipher Pharmaceuticals: Cipher Pharmaceuticals Inc. 2026 Q1 - Results - Earnings Call Presentation
Cipher Pharmaceuticals Competitors
1
2
3
4
5
6
7
8
9
10